Overview and Introduction

References 

1. Sloan JA , Cella D , Frost M , Guyatt GH , Sprangers M , Symonds T , et al.   Assessing clinical significance in measuring oncology patient quality of life (introduction to the symposium, content overview, and definition of terms) . Mayo Clin Proc . 2002;77:367–370
   • Abstract
   • Full Text
   • Full-Text PDF (63 KB)
   • CrossRef
2. Osoba DA . Taxonomy of the uses of health-related quality-of-life instruments in cancer care and the clinical meaningfulness of the results . Med Care . 2002;40(6):31–38 suppl
3. Efficace F , Bottomley A , Osoba D , Gotay C , Flechtner H , D’haese S , et al.   Beyond the development of Health-Related Quality of Life (HRQOL) measures: a checklist for evaluating HRQOL outcomes in cancer trials: does HRQOL evaluation in prostate cancer research inform clinical decision making? . J Clin Oncol . 2003;21(18):3502–3511
   • MEDLINE
   • CrossRef
4. Sloan JA , Dueck A . Issues for statisticians in conducting analyses and translating results for quality of life end points in clinical trials . J Biopharm Stat . 2004;14:73–96
   • MEDLINE
   • CrossRef
5. Cella DF , Bonomi AE . Measuring quality of life (1995 update) . Oncology . 1995;9(11):47–60 suppl
6. Cox DR , Fitzpatrick R . Quality-of-life assessment (can we keep it simple?) . J R Statis Soc . 1992;155:353–393
7. Leplege A , Hunt S . The problem of quality of life in medicine . JAMA . 1997;278(1):47–50
   • MEDLINE